Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul M Keller

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Journal of Clinical Microbiology|December 8, 2005
Novel rotavirus VP7 typing assay using a one-step reverse transcriptase PCR protocol and product sequencing and utility of the assay for epidemiological studies and strain characterization, including serotype subgroup analysisDaniel J DiStefano, Nikolai Kraiouchkine, Laura Mallette, et al.
Vaccine|January 17, 2009
Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeysTong-Ming Fu, Karen M Grimm, Michael P Citron, et al.
Journal of Biomolecular Screening|June 21, 2008
A high-throughput screen for endothelial lipase using HDL as substratePaul M Keller, Timothy Rust, Dennis J Murphy, et al.
The Journal of Biological Chemistry|September 19, 2002
Enhancement of alpha -helicity in the HIV-1 inhibitory peptide DP178 leads to an increased affinity for human monoclonal antibody 2F5 but does not elicit neutralizing responses in vitro. Implications for vaccine designJoseph G Joyce, William M Hurni, Michael J Bogusky, et al.
Biochemistry|December 21, 2006
Solution state characterization of amyloid beta-derived diffusible ligandsRobert W Hepler, Karen M Grimm, Deborah D Nahas, et al.
ACS Infectious Diseases|December 26, 2017
Inhibitors of LexA Autoproteolysis and the Bacterial SOS Response Discovered by an Academic-Industry PartnershipCharlie Y Mo, Matthew J Culyba, Trevor Selwood, et al.
Bioorganic & Medicinal Chemistry Letters|July 8, 2011
Azepanone-based inhibitors of human cathepsin S: optimization of selectivity via the P2 substituentJeffrey K Kerns, Hong Nie, William Bondinell, et al.
Human Gene Therapy|March 17, 2004
Quantitative adenovirus neutralization assays based on the secreted alkaline phosphatase reporter gene: application in epidemiologic studies and in the design of adenovector vaccinesMiguel Aste-Amézaga, Andrew J Bett, Fubao Wang, et al.
The Journal of Infectious Diseases|November 1, 2003
Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccineMyron J Levin, Jeffrey G Smith, Robin M Kaufhold, et al.
Vaccine|November 8, 2005
A recombinant 63-kDa form of Bacillus anthracis protective antigen produced in the yeast Saccharomyces cerevisiae provides protection in rabbit and primate inhalational challenge models of anthrax infectionRobert W Hepler, Rosemarie Kelly, Tessie B McNeely, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of Clinical Microbiology|December 8, 2005
Novel rotavirus VP7 typing assay using a one-step reverse transcriptase PCR protocol and product sequencing and utility of the assay for epidemiological studies and strain characterization, including serotype subgroup analysisDaniel J DiStefano, Nikolai Kraiouchkine, Laura Mallette, et al.
Vaccine|January 17, 2009
Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeysTong-Ming Fu, Karen M Grimm, Michael P Citron, et al.
Journal of Biomolecular Screening|June 21, 2008
A high-throughput screen for endothelial lipase using HDL as substratePaul M Keller, Timothy Rust, Dennis J Murphy, et al.
The Journal of Biological Chemistry|September 19, 2002
Enhancement of alpha -helicity in the HIV-1 inhibitory peptide DP178 leads to an increased affinity for human monoclonal antibody 2F5 but does not elicit neutralizing responses in vitro. Implications for vaccine designJoseph G Joyce, William M Hurni, Michael J Bogusky, et al.
Biochemistry|December 21, 2006
Solution state characterization of amyloid beta-derived diffusible ligandsRobert W Hepler, Karen M Grimm, Deborah D Nahas, et al.
ACS Infectious Diseases|December 26, 2017
Inhibitors of LexA Autoproteolysis and the Bacterial SOS Response Discovered by an Academic-Industry PartnershipCharlie Y Mo, Matthew J Culyba, Trevor Selwood, et al.
Bioorganic & Medicinal Chemistry Letters|July 8, 2011
Azepanone-based inhibitors of human cathepsin S: optimization of selectivity via the P2 substituentJeffrey K Kerns, Hong Nie, William Bondinell, et al.
Human Gene Therapy|March 17, 2004
Quantitative adenovirus neutralization assays based on the secreted alkaline phosphatase reporter gene: application in epidemiologic studies and in the design of adenovector vaccinesMiguel Aste-Amézaga, Andrew J Bett, Fubao Wang, et al.
The Journal of Infectious Diseases|November 1, 2003
Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccineMyron J Levin, Jeffrey G Smith, Robin M Kaufhold, et al.
Vaccine|November 8, 2005
A recombinant 63-kDa form of Bacillus anthracis protective antigen produced in the yeast Saccharomyces cerevisiae provides protection in rabbit and primate inhalational challenge models of anthrax infectionRobert W Hepler, Rosemarie Kelly, Tessie B McNeely, et al.
Pageof 2